ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 528 filers reported holding ASTRAZENECA PLC in Q2 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,708,779 | +1.9% | 25,233 | +7.7% | 0.02% | +5.6% |
| Q2 2023 | $1,676,169 | +3.0% | 23,420 | -0.2% | 0.02% | 0.0% |
| Q1 2023 | $1,626,879 | -4.7% | 23,476 | -6.6% | 0.02% | -10.0% |
| Q4 2022 | $1,707,463 | +25.8% | 25,122 | +1.6% | 0.02% | +11.1% |
| Q3 2022 | $1,357,000 | -4.4% | 24,735 | +15.1% | 0.02% | 0.0% |
| Q2 2022 | $1,419,000 | +8.4% | 21,481 | +8.9% | 0.02% | +28.6% |
| Q1 2022 | $1,309,000 | +18.2% | 19,729 | +4.0% | 0.01% | +16.7% |
| Q4 2021 | $1,107,000 | -5.9% | 18,971 | -3.1% | 0.01% | -14.3% |
| Q3 2021 | $1,176,000 | +10.8% | 19,584 | +10.5% | 0.01% | +16.7% |
| Q2 2021 | $1,061,000 | +28.3% | 17,719 | +6.6% | 0.01% | +9.1% |
| Q1 2021 | $827,000 | -4.4% | 16,623 | -3.7% | 0.01% | -15.4% |
| Q4 2020 | $865,000 | -8.6% | 17,253 | -0.0% | 0.01% | -18.8% |
| Q3 2020 | $946,000 | +10.5% | 17,259 | +6.6% | 0.02% | 0.0% |
| Q2 2020 | $856,000 | +17.6% | 16,188 | -0.9% | 0.02% | +14.3% |
| Q1 2020 | $728,000 | -17.0% | 16,334 | -7.0% | 0.01% | 0.0% |
| Q4 2019 | $877,000 | +9.5% | 17,563 | -2.3% | 0.01% | 0.0% |
| Q3 2019 | $801,000 | +9.1% | 17,973 | +1.0% | 0.01% | 0.0% |
| Q2 2019 | $734,000 | -10.6% | 17,790 | -13.1% | 0.01% | 0.0% |
| Q1 2019 | $821,000 | -30.4% | 20,483 | -34.0% | 0.01% | -39.1% |
| Q4 2018 | $1,179,000 | -8.7% | 31,036 | -4.9% | 0.02% | 0.0% |
| Q3 2018 | $1,292,000 | +17.1% | 32,641 | +3.9% | 0.02% | +4.5% |
| Q2 2018 | $1,103,000 | +60.3% | 31,415 | +59.8% | 0.02% | +57.1% |
| Q1 2018 | $688,000 | +7.2% | 19,662 | +6.2% | 0.01% | +7.7% |
| Q4 2017 | $642,000 | +14.4% | 18,509 | +11.6% | 0.01% | +18.2% |
| Q3 2017 | $561,000 | +6.5% | 16,578 | +7.0% | 0.01% | -8.3% |
| Q2 2017 | $527,000 | +163.5% | 15,487 | +140.0% | 0.01% | +140.0% |
| Q1 2017 | $200,000 | -9.1% | 6,452 | -20.5% | 0.01% | 0.0% |
| Q4 2016 | $220,000 | -70.9% | 8,119 | -64.9% | 0.01% | -73.7% |
| Q3 2016 | $757,000 | +496.1% | 23,100 | +436.5% | 0.02% | +375.0% |
| Q2 2016 | $127,000 | +9.5% | 4,306 | +2.4% | 0.00% | 0.0% |
| Q1 2016 | $116,000 | -21.1% | 4,206 | -4.4% | 0.00% | -20.0% |
| Q4 2015 | $147,000 | +6.5% | 4,399 | +0.3% | 0.01% | 0.0% |
| Q3 2015 | $138,000 | -9.2% | 4,388 | +80.4% | 0.01% | 0.0% |
| Q2 2015 | $152,000 | -4.4% | 2,432 | +3.6% | 0.01% | 0.0% |
| Q1 2015 | $159,000 | +10.4% | 2,347 | +13.1% | 0.01% | 0.0% |
| Q4 2014 | $144,000 | -6.5% | 2,075 | -4.5% | 0.01% | 0.0% |
| Q3 2014 | $154,000 | -16.3% | 2,173 | -13.1% | 0.01% | -16.7% |
| Q2 2014 | $184,000 | -60.9% | 2,500 | -65.6% | 0.01% | -64.7% |
| Q1 2014 | $470,000 | -3.1% | 7,262 | -11.6% | 0.02% | -5.6% |
| Q4 2013 | $485,000 | +37.0% | 8,214 | +19.8% | 0.02% | +12.5% |
| Q3 2013 | $354,000 | +1.7% | 6,855 | -7.2% | 0.02% | -5.9% |
| Q2 2013 | $348,000 | – | 7,385 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |